The CECARI Study: Everolimus (Certican®) Initiation and Calcineurin Inhibitor Withdrawal in Maintenance Heart Transplant Recipients with Renal Insufficiency: A Multicenter, Randomized Trial

In this 3-year, open-label, multicenter study, 57 maintenance heart transplant recipients (>1 year after transplant) with renal insufficiency (eGFR 30–60 mL/min/1.73 m(2)) were randomized to start everolimus with CNI withdrawal (N = 29) or continue their current CNI-based immunosuppression (N = 2...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Transplant
Main Authors: Van Keer, Jan, Derthoo, David, Van Caenegem, Olivier, De Pauw, Michel, Nellessen, Eric, Duerinckx, Nathalie, Droogne, Walter, Vörös, Gábor, Meyns, Bart, Belmans, Ann, Janssens, Stefan, Van Cleemput, Johan, Vanhaecke, Johan
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2017
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5337890/
https://ncbi.nlm.nih.gov/pubmed/28316834
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/6347138
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados